Christopher W. Fulton

Array ( [id] => 5788409 [patent_doc_number] => 20020160961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Compositions for the treatment of the catabolic state of prolonged critical illness' [patent_app_type] => new [patent_app_number] => 10/004648 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6434 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160961.pdf [firstpage_image] =>[orig_patent_app_number] => 10004648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510666 [patent_doc_number] => 07199217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Amidated glucagon-like peptide-1' [patent_app_type] => utility [patent_app_number] => 10/450042 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12073 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/199/07199217.pdf [firstpage_image] =>[orig_patent_app_number] => 10450042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624280 [patent_doc_number] => 20020065391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists' [patent_app_type] => new [patent_app_number] => 09/995631 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30587 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20020065391.pdf [firstpage_image] =>[orig_patent_app_number] => 09995631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 671854 [patent_doc_number] => 07090869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'Method for producing preparation containing bioactive substance' [patent_app_type] => utility [patent_app_number] => 10/433156 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22608 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/090/07090869.pdf [firstpage_image] =>[orig_patent_app_number] => 10433156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082970 [patent_doc_number] => 20020082384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Process for folding chemically synthesized polypeptides' [patent_app_type] => new [patent_app_number] => 09/995335 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5902 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082384.pdf [firstpage_image] =>[orig_patent_app_number] => 09995335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037656 [patent_doc_number] => 06872805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-29 [patent_title] => 'Hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 10/001850 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55022 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872805.pdf [firstpage_image] =>[orig_patent_app_number] => 10001850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413982 [patent_doc_number] => 06525026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-25 [patent_title] => 'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => B2 [patent_app_number] => 09/987900 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85515 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525026.pdf [firstpage_image] =>[orig_patent_app_number] => 09987900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536394 [patent_doc_number] => 20020193312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => new [patent_app_number] => 09/987619 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87100 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193312.pdf [firstpage_image] =>[orig_patent_app_number] => 09987619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721362 [patent_doc_number] => 20030055052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'FAP-activated anti-tumor compounds' [patent_app_type] => new [patent_app_number] => 10/036111 [patent_app_country] => US [patent_app_date] => 2001-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10105 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055052.pdf [firstpage_image] =>[orig_patent_app_number] => 10036111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6473409 [patent_doc_number] => 20020151504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'STAT modulators' [patent_app_type] => new [patent_app_number] => 10/008244 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16719 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151504.pdf [firstpage_image] =>[orig_patent_app_number] => 10008244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1025166 [patent_doc_number] => 06884869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Pentapeptide compounds and uses related thereto' [patent_app_type] => utility [patent_app_number] => 10/001191 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 22783 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884869.pdf [firstpage_image] =>[orig_patent_app_number] => 10001191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683882 [patent_doc_number] => 20030119746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Hepta-and octapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/000633 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8577 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 432 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119746.pdf [firstpage_image] =>[orig_patent_app_number] => 10000633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683881 [patent_doc_number] => 20030119745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'HEXA- and heptapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/000540 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12046 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 386 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119745.pdf [firstpage_image] =>[orig_patent_app_number] => 10000540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761897 [patent_doc_number] => 20030125259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Octa- and nonapeptides having antiangiogenic activity' [patent_app_type] => new [patent_app_number] => 10/000681 [patent_app_country] => US [patent_app_date] => 2001-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10574 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125259.pdf [firstpage_image] =>[orig_patent_app_number] => 10000681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383264 [patent_doc_number] => 20020120151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Composition and device for detecting leukocytes in urine' [patent_app_type] => new [patent_app_number] => 10/004540 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3949 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120151.pdf [firstpage_image] =>[orig_patent_app_number] => 10004540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291414 [patent_doc_number] => 20020055463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same' [patent_app_type] => new [patent_app_number] => 09/977349 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10278 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055463.pdf [firstpage_image] =>[orig_patent_app_number] => 09977349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131250 [patent_doc_number] => 20020077279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Manufacture of polyglutamate-therapeutic agent conjugates' [patent_app_type] => new [patent_app_number] => 09/971657 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9072 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077279.pdf [firstpage_image] =>[orig_patent_app_number] => 09971657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440198 [patent_doc_number] => 20020128293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Stable oral pharmaceutical composition containing omeprazole' [patent_app_type] => new [patent_app_number] => 09/973265 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3912 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128293.pdf [firstpage_image] =>[orig_patent_app_number] => 09973265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 424850 [patent_doc_number] => 07270832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation' [patent_app_type] => utility [patent_app_number] => 10/398134 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6969 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/270/07270832.pdf [firstpage_image] =>[orig_patent_app_number] => 10398134 [rel_patent_id] =>[rel_patent_doc_number] =>)